VUG vs. VTI: Which Vanguard ETF Is the Better Buy for Growth Stocks?
Investors are grappling with a big question right now: Are U.S. growth stocks overvalued? The artificial intelligence (AI) trade has driven massive gains for growth stock investors in the past few years, but there are reasons to wonder if that momentum can continue.
Recent Vanguard research projects that U.S. value stocks will outperform U.S.
» Read more about: VUG vs. VTI: Which Vanguard ETF Is the Better Buy for Growth Stocks? »
Read MoreHere's the “Magnificent Seven” Stock Cathie Wood Is Piling Into Now
Cathie Wood, the CEO and chief investment officer of Ark Investment Management, has been directing her firm to load up on shares of Meta Platforms (NASDAQ: META), the parent company of Facebook, Instagram, and WhatsApp. Wood’s investment management firm purchased 34,080 shares of the technology company in recent weeks, which, at today’s share price of around $584,
» Read more about: Here's the “Magnificent Seven” Stock Cathie Wood Is Piling Into Now »
Read MoreSocial Security is paid out on Monday, August 3: who benefits?
In the U.S., certain Social Security beneficiaries are to get their latest monthly money early next week, as the Social Security Administration (SSA) kicks off the program’s payment schedule for August 2026.
On Monday, August 3, Social Security benefits are due to be sent out to two groups of recipients.
» Read more about: Social Security is paid out on Monday, August 3: who benefits? »
Read MoreCathie Wood’s ARK Buys The Dip As SpaceX Wipes Out Tesla-Sized Market Value Since Its Peak: Retail Bears Smell Blood
SPCX has erased more than $1.2 trillion in market value since its June peak of $225.64, roughly equivalent to Tesla’s market cap. Cathie Wood remains bullish, calling Starship’s latest splashdown potentially “game-changing” despite the stock falling below its IPO price. SpaceX faces two major near-term catalysts: its first public earnings report on Aug.4 and a potential release of up to 911.5 million locked-up shares on Aug.6.
Read MoreWill Generic Drug Tariffs Impact Pharma ETFs?
U.S. President Donald Trump’s recently proposed tariffs on imported generic drugs aim to encourage domestic drug manufacturing and are expected to increase costs in the near future for generic drugs, which are imported into the United States.
Trump announced on July 21, 2026, that imported generic medicines will remain tariff-free for two years beginning Aug.
» Read more about: Will Generic Drug Tariffs Impact Pharma ETFs? »
Read MoreThe Burst
Nearly 200% Higher, Will This Space Stock Keep Soaring?
Planet Labs combines satellite imaging and data analytics technologies to provide a service valuable to government agencies, corporations, and non-governmental organizations. The company has been developing its unique technology for 14 years, but it didn’t become a publicly traded company until 2021.
» Read more about: Nearly 200% Higher, Will This Space Stock Keep Soaring? »
Read MoreThe Ivy
Billionaire Loves These Stocks Most of All
Stanley Druckenmiller doesn’t toss around stock picks like confetti. When he makes a move, it matters not just because of his track record (which is ridiculous by the way) but because his strategy blends macro trends with razor-sharp stock selection.
In 2025, he’s not chasing headlines. He’s making some bold, high-conviction bets, and a few of them are pretty surprising.
» Read more about: Billionaire Loves These Stocks Most of All »
Read MoreThe Spotlight
The Greatest Trader In History?
Sometimes if you can’t beat ’em, you just have to join ’em. That might well be the case when it comes to Nancy Pelosi’s investment portfolio.
In online forums, her extraordinary outperformance has received enormous attention. How did Nancy Pelosi generate so much wealth on a politician’s salary is a common refrain.
Recently,